Abstract:Abstract Genomic instability is the hallmark of various cancers with the increasing accumulation of DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is typically based on this property of cancers. However, the adverse effects including normal tissues injury are also accompanied by the radiotherapy and chemotherapy. Targeted cancer therapy has the potential to suppress cancer cells’ DNA damage response through tailoring therapy to cancer patients lacking specific DNA damage response functions. Obviously, understanding the broader role of DNA damage repair in cancers has became a basic and attractive strategy for targeted cancer therapy, in particular, raising novel hypothesis or theory in this field on the basis of previous scientists’ findings would be important for future promising druggable emerging targets. In this review, we first illustrate the timeline steps for the understanding the roles of DNA damage repair in the promotion of cancer and cancer therapy developed, then we summarize the mechanisms regarding DNA damage repair associated with targeted cancer therapy, highlighting the specific proteins behind targeting DNA damage repair that initiate functioning abnormally duo to extrinsic harm by environmental DNA damage factors, also, the DNA damage baseline drift leads to the harmful intrinsic targeted cancer therapy. In addition, clinical therapeutic drugs for DNA damage and repair including therapeutic effects, as well as the strategy and scheme of relative clinical trials were intensive discussed. Based on this background, we suggest two hypotheses, namely “environmental gear selection” to describe DNA damage repair pathway evolution, and “DNA damage baseline drift”, which may play a magnified role in mediating repair during cancer treatment. This two new hypothesis would shed new light on targeted cancer therapy, provide a much better or more comprehensive holistic view and also promote the development of new research direction and new overcoming strategies for patients.

DNA damage and the balance between survival and death in cancer biology

The DNA damage-induced cell death response: a roadmap to kill cancer cells

DNA damage, aging, and cancer.

DNA Damage and Its Role in Cancer Therapeutics

DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

The DNA damage response: putting checkpoints in perspective

Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

DNA Damage Checkpoint Recovery and Cancer Development

The DNA-damage response in human biology and disease

Recent advances in DNA damage repair mechanism

Targeting DNA damage response pathways in cancer

Mechanisms of DNA damage, repair, and mutagenesis

The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

Autophagy and DNA damage repair

DNA damage checkpoint kinases in cancer

Complex Interplay between DNA Damage and Autophagy in Disease and Therapy

DNA Damage/Repair Management in Cancers

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies

DNA Repair Pathways in Cancer Therapy and Resistance.